Haemonetics Releases TEG® 6s PlateletMapping® ADP & AA Assay Cartridge Globally
The PlateletMapping ADP & AA cartridge is used by clinicians to assess a patient's bleeding and thrombotic risk due to inhibition of platelet function caused by anticoagulants such as aspirin. By providing four channels of dried-in-place reagents including HKH (Kaolin with Heparinase), ActF (Activator F), ADP (adenosine-5'-diphosphate) and AA (Arachidonic Acid), the cartridge can help clinicians measure a patient's ability to coagulate, or form a blood clot.
"The release of the PlateletMapping ADP & AA cartridge marks another milestone in our commitment to developing meaningful technologies that help improve the efficiency and effectiveness of care in critical areas of medicine," said Stew Strong, President,
"Platelet function can be affected by factors such as genetics, antiplatelet therapy or surgical procedures," said
The PlateletMapping ADP & AA cartridge is now available for use with the TEG 6s system in a number of countries within
About
Investor Contact: |
Media Contact: |
Olga Guyette, Director-Investor Relations |
Carla Burigatto, VP-Communications |
(781) 356-9763 |
(781) 348-7263 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-releases-teg-6s-plateletmapping-adp--aa-assay-cartridge-globally-300961962.html
SOURCE